Home › Products › Oncology › Etbmed 150mg Tablet
Etbmed 150mg Tablet
Salt Composition: ERLOTINIB
- Manufacturer: MEDICAMEN BIOTECH LTD
- Pack Size: 30 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 150MG
- Prescription Required
- Storage: Keep out of sight and reach of children. Store at controlled room temperature between 15°C to 30°C. Do not freeze.
₹2622.00₹6243.00
Inclusive of all taxes
Product Introduction
ETBmed 150mg Tablet is an anticancer medicine containing erlotinib. It is used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. For patients with metastatic or advanced pancreatic cancer, it is usually given in combination with gemcitabine, another anticancer medicine. Inform your doctor if you use contact lenses, have an intolerance to sugars, have a history of eye problems, or take medicines for clotting disorders or cholesterol. ETBmed 150mg can cause eye dryness and conjunctivitis; patients should inform their doctor of any history of vision problems and contact lens use before taking this medication. ETBmed 150mg Tablet is not recommended for adolescents and children under 18 years of age. Do not take this medication with food. Use effective birth control during treatment and for at least 2 weeks after the last dose. Patients are advised not to smoke while being treated with ETBmed 150mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform your physician if you experience symptoms such as eye pain, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhoea while taking this medicine.
Uses
Advanced or metastatic non-small lung cancer (NSCLC) Advanced or metastatic pancreatic cancer
How it works
Erlotinib in ETBmed 150mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
How to Use
Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. The Inlyta side effects are: Serious side effects of Etbmed 150mg Tablet are: Persistent or severe diarrhoea Pain in the eye, blurred vision Sudden difficulty in breathing accompanied by cough and fever Severe pain in your abdomen Liver failure Common side effects of Etbmed 150mg Tablet are: Rash worsened in sun-exposed areas Loss of appetite decreased weight Infection Headache Depression Nausea Mouth irritation Indigestion Hair loss, dry skin, itching, acne, cracked skin Tiredness Inflammation around fingernail Bleeding from nose, stomach, intestines Reduced kidney function
Expert Tips
Inform the doctor if you have vision problems, are using contact lenses, have clotting disorders, intolerance to sugar, and taking any medication for cholesterol before starting this medication. This medication should not be taken along with the food, and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney, and liver disorders, as this medication is not recommended in patients with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.
References
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737.
- Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
- Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf
Safety Advice
Pregnancy: unsafe Taking ETBmed 150mg Tablet while pregnant can harm the baby. Do not take this medicine during pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Lungs: Consult your doctor It is unknown whether ETBmed 150mg Tablet affect the lungs. Please consult your doctor.
Breastfeeding: unsafe Do not take Etbmed 150 Mg Tablet 30 if you are breastfeeding. Consult the doctor for risks and benefits.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.